| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/11/2006 | US20060099144 Tumor association of MDL-1 and methods |
| 05/11/2006 | US20060099143 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| 05/11/2006 | US20060099142 Cancer associated araf1 protein kinase and its uses |
| 05/11/2006 | DE3571648C5 Monoklonale Antikörper gegen menschlichen Brustkrebs, ihre Produktion und Verwendung, Hybridomen zu ihrer Herstellung und Herstellung dieser Hybridomen. Monoclonal antibodies against human breast cancer, their production and use, hybridomas for their preparation and production of these hybridomas. |
| 05/11/2006 | CA2595398A1 Treatment of b-cell malignancies |
| 05/11/2006 | CA2586844A1 Ctla-4 antibody and aromatase inhibitor or combination treatment for breast cancer |
| 05/11/2006 | CA2586067A1 Immunoglobulin fractions |
| 05/11/2006 | CA2586058A1 Modified streptococcal polysaccharides and uses thereof |
| 05/11/2006 | CA2585891A1 Methods of preventing and treating rsv infections and related conditions |
| 05/11/2006 | CA2585672A1 Combination approaches for generating immune responses |
| 05/11/2006 | CA2585574A1 Broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
| 05/11/2006 | CA2581300A1 Composition comprising vlp and amyloid-beta peptide |
| 05/11/2006 | CA2566535A1 Ige-retargeting, function-altering molecules (erfam) for treatment of allergic diseases |
| 05/10/2006 | EP1655607A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
| 05/10/2006 | EP1655605A2 Treatment and diagnosis of cancer |
| 05/10/2006 | EP1655382A2 Colon specific gene and protein |
| 05/10/2006 | EP1655367A1 Modulators of tissue regeneration |
| 05/10/2006 | EP1655306A1 Protective antigenes and vaccines for the control of multi species tick infestations |
| 05/10/2006 | EP1655305A2 Therapeutic anti-cytomegalovirus compounds |
| 05/10/2006 | EP1655039A2 Immunoliposomes that optimize internalization into target cells |
| 05/10/2006 | EP1654390A2 Liquid crystal based analyte detection |
| 05/10/2006 | EP1654378A2 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 05/10/2006 | EP1654370A2 Accelerated vaccination |
| 05/10/2006 | EP1654364A2 Inactivated host cell delivery of polynucleotides encoding immunogens |
| 05/10/2006 | EP1654353A2 Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses threreof |
| 05/10/2006 | EP1654302A1 Thermosensitive poly (organophosphazenes), preparation method thereof and injectable thermosensitive polyphosphazene hydrogels using the same |
| 05/10/2006 | EP1654287A2 Cd20-binding polypeptide compositions |
| 05/10/2006 | EP1653999A1 Compositions and methods for manipulating levels antigen-specific antibodies in a mammal |
| 05/10/2006 | EP1653998A2 Rabbit bacterium and uses thereof |
| 05/10/2006 | EP1653912A2 Vaccine immunotherapy for immune suppressed patients |
| 05/10/2006 | EP1653801A2 Altered antibodies having improved antigen-binding affinity |
| 05/10/2006 | EP1483374B1 Use of l-alpha-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vitro |
| 05/10/2006 | EP1320609B1 Isolated peptides which bind to hla-c molecules and uses thereof |
| 05/10/2006 | EP1307189B1 Use of hydroxyethylrutosides for treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 05/10/2006 | EP1265631B1 Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant |
| 05/10/2006 | EP1214091B1 Therapies for chronic renal failure using one or more integrin antagonists |
| 05/10/2006 | EP1210355B1 Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 05/10/2006 | EP1185297B1 Streptococcus pneumoniae proteins and vaccines |
| 05/10/2006 | EP1015026B1 Il-12 as an adjuvant for bordetella pertussis vaccines |
| 05/10/2006 | EP1006782B1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid |
| 05/10/2006 | EP1003548B1 Device for inducing a ctl response |
| 05/10/2006 | EP0990001B1 Processes for production of immunoglobulin a in milk |
| 05/10/2006 | EP0972055B1 METHOD FOR PRODUCING PURIFIED AND MARKED TSH RECEPTOR PREPARATIONS AND THE USE OF the corresponding PREPARATIONS IN DIAGNOSTICS |
| 05/10/2006 | EP0809700B1 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 05/10/2006 | EP0721505B2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 05/10/2006 | CN1771338A High affinity anti-human IgE antibodies |
| 05/10/2006 | CN1771329A The use of PDE4D in the screening for medicaments against atherosclerosis |
| 05/10/2006 | CN1771261A Antibodies against insulin-like growth factor I receptor and thereof |
| 05/10/2006 | CN1771057A Releasable polymeric conjugates based on biodegradable linkers |
| 05/10/2006 | CN1771056A Severe acute respiratory syndrome associated antibodies and method for detecting them and use thereof |
| 05/10/2006 | CN1771055A Methods of preventing or treating T cell malignancies by administering CD2 antagonists |
| 05/10/2006 | CN1771054A Improved vaccines |
| 05/10/2006 | CN1771053A Immunoglobulin formulation and method of preparation thereof |
| 05/10/2006 | CN1771052A Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
| 05/10/2006 | CN1769465A Recombinant chicken poxvirus alive vector vaccine rFPV-12LSF expressing newcastle disease F gene and its construction method |
| 05/10/2006 | CN1769464A Recombinant chicken poxvirus alive vector vaccine rFPV-12LSHN expressing newcastle disease HN gene and its construction method |
| 05/10/2006 | CN1769435A Porcine circus-virus 2 type recombinant adenovirus and vaccine |
| 05/10/2006 | CN1769434A Porcine circus-virus 2 type recombinant adenovirus and its construction method and uses |
| 05/10/2006 | CN1769298A Fusion protein with antitumour action and its coding gene and uses |
| 05/10/2006 | CN1768861A Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 05/10/2006 | CN1255543C Expression and application of transduction peptides - human insulinogen fusion protein |
| 05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
| 05/10/2006 | CN1255427C Method and composition for treating liver cell cancer |
| 05/09/2006 | US7041870 Transgenic mammal for use in the treatmnent of cardiovascular, infections, cancer and autoimmune disorders |
| 05/09/2006 | US7041813 Canine herpes virus alpha transinducing factor nucleic acid molecules |
| 05/09/2006 | US7041806 Netrin receptors |
| 05/09/2006 | US7041805 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferation and tumor disorders |
| 05/09/2006 | US7041804 Antibodies to PRO1387 polypeptides |
| 05/09/2006 | US7041798 Method for the chromatographic fractionation of plasma or serum, preparations, so obtained, and their use |
| 05/09/2006 | US7041796 C3b/C4b Complement Receptor-like molecules and uses thereof |
| 05/09/2006 | US7041792 Polypeptide free of botulinum toxin activity and free of toxoid which induces protective immunity to a type F botulinum toxin; vaccines; fusion protein with polypeptide for enhanced chromatographic purification |
| 05/09/2006 | US7041646 Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists |
| 05/09/2006 | US7041502 Immunology active materials; complexing to major histocompatibility complex |
| 05/09/2006 | US7041500 Insect cell line |
| 05/09/2006 | US7041478 Polypeptide for use in the treatment cancer, inflammation of autoimmune disorders |
| 05/09/2006 | US7041462 analyzing a non-denatured protein by high pressure liquid chromatography; by using chimeric genes replacing a native signal sequence with a different signal sequence resulting in the production of a conformer, one can compare the native protein with the product of the chimeric gene |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041444 Murine calicivirus |
| 05/09/2006 | US7041443 For therapy of porcine subject at risk of infection by, or displaying symptoms of, a porcine reproductive and respiratory syndrome virus infection |
| 05/09/2006 | US7041442 peptides or derivatives of the 65 kD lower matrix phoshpoprotein of HCMV useful for determining whether subjects have been exposed to the virus and for determining the peptide-induced production of interferon- gamma and/or TNF- alpha in CD8+ T cells isolated from subjects |
| 05/09/2006 | US7041302 Therapeutic modulation of the tumor inflammatory response |
| 05/09/2006 | US7041300 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 05/09/2006 | US7041299 vaccine against Newcastle Disease contains one or more mutant immunogens of the NDW strain that lack the antigenic binding site on the F glycoprotein which is recognized by the monoclonal antibody mAb 54. |
| 05/09/2006 | US7041298 Regulating protein activity with an ubiquitin pathway protein binding moiety coupled to a targeting moiety; used to perform target ubiquitination |
| 05/09/2006 | US7041297 Tumor antigen peptides originating in cyclophilin B |
| 05/09/2006 | US7041296 especially Crohn's disease; administered mucosally and not with an antigen; decreasing the activity of interferon gamma |
| 05/09/2006 | US7041295 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 05/09/2006 | US7041294 Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects |
| 05/09/2006 | US7041293 HIV env antibodies |
| 05/09/2006 | US7041292 binds ErbB2, blocks ligand activation of an ErbB receptor more effectively than humanized monoclonal antibody huMAb4D5-8 and blocks by 50% or greater binding of monoclonal antibody 2C4 (ATCC HB12697) to ErbB2. |
| 05/09/2006 | US7041291 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 05/09/2006 | US7041290 isolated monoclonal antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide of an epitope within or overlapping the amino acid sequence: SSDGLWNNNQTQLFLEHS; treating or preventing renal disease or injury |
| 05/09/2006 | US7041289 administering one or more of CD3 antibodies and or their fragments to treat diabetes; possible to achieve permanent disease remission through the induction of antigen-specific unresponsiveness, i.e. immune tolerance. |
| 05/09/2006 | US7041288 Antiinflammatory agents; antiallergens |
| 05/09/2006 | CA2245588C Polysaccharide precipitation process |
| 05/09/2006 | CA2156857C Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 05/09/2006 | CA1341505C Intravenously administered polyclonal immunoglobulin preparation containing igm and method of manufacture |
| 05/04/2006 | WO2006047759A2 Kinase inhibitors for the treatment of diabetes and obesity |
| 05/04/2006 | WO2006047684A2 Tissue factor phospholipid vesicle particles and methods of use for coagulation |
| 05/04/2006 | WO2006047670A2 Methods for assessing antibodies to neurodegenerative disease-associated antigens |